Published in Mol Immunol on January 07, 2015
Serum Interleukin-18 and Its Gene Haplotypes Profile as Predictors in Patients with Diabetic Nephropathy. Open Access Maced J Med Sci (2016) 0.75
Per os colchicine administration in cholesterol fed rabbits: Triglycerides lowering effects without affecting atherosclerosis progress. Lipids Health Dis (2017) 0.75
Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med (2006) 6.71
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol (2011) 6.53
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation (2002) 6.26
Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol (2012) 4.72
The interleukin-1 family: back to the future. Immunity (2013) 3.90
IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol (1999) 3.81
A comprehensive review on metabolic syndrome. Cardiol Res Pract (2014) 3.47
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med (2006) 2.86
Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol (1996) 2.80
Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol (2005) 2.17
Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci U S A (2000) 2.03
A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun (1995) 1.99
A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc Natl Acad Sci U S A (2002) 1.78
IL-18 in autoimmunity: review. Eur Cytokine Netw (2006) 1.76
Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring) (2006) 1.59
Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) (2012) 1.58
Inflammasomes and autoimmunity. Trends Mol Med (2010) 1.53
A comparison of several methods for analyzing censored data. Ann Occup Hyg (2007) 1.43
A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine (2001) 1.41
The role of interleukin-18 in the metabolic syndrome. Cardiovasc Diabetol (2010) 1.23
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol (2007) 1.20
Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr (2010) 1.15
Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion. J Biol Chem (2013) 1.15
Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol (2005) 1.13
Role of cytokines in the pathogenesis of autoimmune diabetes mellitus. Rev Endocr Metab Disord (2003) 1.11
IL-18 in inflammatory and autoimmune disease. Cell Mol Life Sci (2013) 1.06
Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis. J Interferon Cytokine Res (2011) 1.04
Circulating IL-18 and the risk of type 2 diabetes in women. Diabetologia (2009) 1.04
Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals. Ann N Y Acad Sci (2013) 1.02
Interleukin-37. Semin Immunol (2013) 1.00
Cytokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care (2003) 1.00
Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma. Eur Cytokine Netw (2000) 0.99
Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor. Proc Natl Acad Sci U S A (2006) 0.98
An association of autoantibody status and serum cytokine levels in type 1 diabetes. Diabetes (2003) 0.96
High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun (2009) 0.95
Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia (2001) 0.93
Autophagy and IL-1 Family Cytokines. Front Immunol (2013) 0.92
Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus. Eur Cytokine Netw (2010) 0.91
RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes. Diabetes (2011) 0.90
Type 1 diabetes, metabolic syndrome and cardiovascular risk. Metabolism (2013) 0.89
Functional IL-18 Is produced by primary pancreatic mouse islets and NIT-1 beta cells and participates in the progression towards destructive insulitis. Horm Res (2002) 0.88
Serum IL-18 levels in patients with type 1 diabetes: relations to metabolic control and microvascular complications. Cytokine (2008) 0.87
HbA1c as a Diagnostic Test for Diabetes Mellitus - Reviewing the Evidence. Clin Biochem Rev (2013) 0.86
Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes. Endocr J (2013) 0.86
Interleukin-18 and Crohn's disease. Digestion (2001) 0.85
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis. J Neuroinflammation (2014) 0.85
Serum interleukin-18 levels are increased and closely associated with various soluble adhesion molecule levels in type 1 diabetic patients. Diabetes Care (2007) 0.84
Increased serum levels of interleukin-18 in patients with multiple sclerosis. Neurology (2001) 0.84
Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4(+)CD25 (high)FOXP3 (+) regulatory t cells in young patients with type 1 diabetes. Inflammation (2014) 0.83
IL-18 induces airway hyperresponsiveness and pulmonary inflammation via CD4+ T cell and IL-13. PLoS One (2013) 0.82
IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clin Immunol (2005) 0.81
Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice. J Autoimmun (1997) 0.80
Thyrocyte interleukin-18 expression is up-regulated by interferon-γ and may contribute to thyroid destruction in Hashimoto's thyroiditis. Int J Exp Pathol (2010) 0.80
IL-18 is required for self-reactive T cell expansion in NOD mice. J Autoimmun (2011) 0.80
Serum interleukin-18 levels are raised in diabetic ketoacidosis in Chinese children with type 1 diabetes mellitus. Indian Pediatr (2007) 0.79
Increased serum levels of the interferon-gamma-inducing cytokine interleukin-18 in myasthenia gravis. Neurology (2002) 0.79
The role of IL-18 in Th1/Th2 balance in children. Allergy Asthma Proc (2006) 0.78